Dominance of furosemide for loop diuretic therapy in heart failure: Time to revisit the alternatives?

Journal of the American College of Cardiology

Volumn 61, Issue 14, 2013, Pages 1549-1550

  Bikdeli, Behnood ^a,b   Strait, Kelly M ^a   Dharmarajan, Kumar ^a,c   Partovian, Chohreh ^a,b   Coca, Steven G ^a   Kim, Nancy ^a   Li, Shu Xia ^a   Testani, Jeffrey M ^b   Khan, Usman ^a   Krumholz, Harlan M ^a,b,d  

^a YALE NEW HAVEN HOSPITAL   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c New York Presbyterian Morgan Stanley Children's Hospital   (United States)

^d YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUMETANIDE; FUROSEMIDE; TORASEMIDE;

COST CONTROL; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FUNCTIONAL ASSESSMENT; FUNCTIONAL STATUS; HEART FAILURE; HOSPITALIZATION; HUMAN; LETTER; MORTALITY; PRIORITY JOURNAL;

DATABASES, FACTUAL; FEMALE; FOLLOW-UP STUDIES; FUROSEMIDE; HEART FAILURE; HUMANS; MALE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SODIUM POTASSIUM CHLORIDE SYMPORTER INHIBITORS; SULFONAMIDES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84875776338     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2012.12.043     Document Type: Letter

References (11)

1. The Digitalis Investigators Group Rationale, design, implementation, and baseline characteristics of patients in the DIG trial: a large, simple, long-term trial to evaluate the effect of digitalis on mortality in heart failure Control Clin Trials 17 1996 77 97
2. The SOLVD Investigators Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure N Engl J Med 325 1991 293 302
3. W.F. Peacock, M.R. Costanzo, T. De Marco ADHERE Scientific Advisory Committee and Investigators Impact of intravenous loop diuretics on outcomes of patients hospitalized with acute decompensated heart failure: insights from the ADHERE registry Cardiology 113 2009 12 19
4. M.D. Murray, M.M. Deer, J.A. Ferguson Open-label randomized trial of torsemide compared with furosemide therapy for patients with heart failure Am J Med 111 2001 513 520
5. J. Cosin, J. Diez TORIC Investigators Torasemide in chronic heart failure: results of the TORIC study Eur J Heart Fail 4 2002 507 513
6. K. Müller, G. Gamba, F. Jaquet, B. Hess Torasemide vs. furosemide in primary care patients with chronic heart failure NYHA II to IV - efficacy and quality of life Eur J Heart Fail 5 2003 793 801
7. T. Masuyama, T. Tsujino, H. Origasa Superiority of long-acting to short-acting loop diuretics in the treatment of congestive heart failure Circ J 76 2012 833 842
8. S. Kasama, T. Toyama, T. Hatori Effects of torasemide on cardiac sympathetic nerve activity and left ventricular remodelling in patients with congestive heart failure Heart 92 2006 1434 1440
9. B. López, A. González, J. Beaumont, R. Querejeta, M. Larman, J. Díez Identification of a potential cardiac antifibrotic mechanism of torasemide in patients with chronic heart failure J Am Coll Cardiol 50 2007 859 867
10. TORAFIC Investigators Group Effects of prolonged-release torasemide versus furosemide on myocardial fibrosis in hypertensive patients with chronic heart failure: a randomized, blinded-end point, active-controlled study Clin Ther 33 2011 1204 1213.e3
11. K.T. Stroupe, M.M. Forthofer, D.C. Brater, M.D. Murray Healthcare costs of patients with heart failure treated with torasemide or furosemide Pharmacoeconomics 17 2000 429 440